Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial
暂无分享,去创建一个
J. Debus | Michael Thomas | F. Lasitschka | M. Kieser | P. Huber | J. Krisam | L. König | F. Bozorgmehr | S. Rieken | A. Hommertgen | J. Kuon | M. Maenz